531
  Mrv0541 02231214452D          

 14 14  0  0  1  0            999 V2000
    1.6500   -0.8250    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.1251   -2.2540    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    4.1251    0.6040    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    4.8396    1.0165    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5376   -0.1106    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126   -0.1106    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4106    1.0165    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4106    1.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1251    2.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8396    1.8415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8876   -0.1106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1251   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4751   -0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7126   -1.5395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 13  1  0  0  0  0
  2 14  1  0  0  0  0
  3  4  1  0  0  0  0
  3  5  2  0  0  0  0
  3  6  1  0  0  0  0
  3  7  1  0  0  0  0
  4 10  1  0  0  0  0
  6 11  1  0  0  0  0
  6 12  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
 11 13  1  0  0  0  0
 12 14  1  0  0  0  0
M  END
> <DATABASE_ID>
DB00531

> <DATABASE_NAME>
drugbank

> <SMILES>
ClCCN(CCCl)P1(=O)NCCCO1

> <INCHI_IDENTIFIER>
InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)

> <INCHI_KEY>
CMSMOCZEIVJLDB-UHFFFAOYSA-N

> <FORMULA>
C7H15Cl2N2O2P

> <MOLECULAR_WEIGHT>
261.086

> <EXACT_MASS>
260.02481966

> <JCHEM_ACCEPTOR_COUNT>
1

> <JCHEM_ATOM_COUNT>
29

> <JCHEM_AVERAGE_NEUTRAL_MICROSPECIES_CHARGE>
-3.3377725110776e-07

> <JCHEM_AVERAGE_POLARIZABILITY>
23.722394450622833

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
1

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
1

> <JCHEM_IUPAC>
2-[bis(2-chloroethyl)amino]-1,3,2lambda5-oxazaphosphinan-2-one

> <ALOGPS_LOGP>
0.76

> <JCHEM_LOGP>
0.09654768666666613

> <ALOGPS_LOGS>
-1.24

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NEUTRAL_CHARGE>
0

> <JCHEM_NUMBER_OF_RINGS>
1

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <JCHEM_PKA_STRONGEST_ACIDIC>
13.476543121426038

> <JCHEM_POLAR_SURFACE_AREA>
41.57

> <JCHEM_REFRACTIVITY>
58.47810000000002

> <JCHEM_ROTATABLE_BOND_COUNT>
5

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
1.51e+01 g/l

> <JCHEM_TRADITIONAL_IUPAC>
tetrahydrofolic acid

> <JCHEM_VEBER_RULE>
0

> <DRUGBANK_ID>
DB00531

> <SECONDARY_ACCESSION_NUMBERS>
APRD00408

> <DRUG_GROUPS>
approved; investigational

> <GENERIC_NAME>
Cyclophosphamide

> <SYNONYMS>
(+-)-Cyclophosphamide; (±)-2-(BIS(2-CHLOROETHYL)AMINO)TETRAHYDRO-2H-1,3,2-OXAZAPHOSPHORINE 2-OXIDE MONOHYDRATE; (RS)-Cyclophosphamide; 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide; Anhydrous cyclophosphamide; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; Ciclofosfamida; Ciclofosfamide; Cyclophosphamid; Cyclophosphamide; Cyclophosphamide anhydrous; Cyclophosphamidum; Cytophosphane; N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

> <PRODUCTS>
Cyclophosphamide; Cyclophosphamide for Injection; Cytoxan; Cytoxan Pws for Inj 1000mg/vial; Cytoxan Pws for Inj 2000mg/vial; Cytoxan Tab 25mg; Cytoxan Tab 50mg; Procytox; Procytox Pws 500mg; Procytox Tab 25mg; Procytox Tab 50mg; Procytox Tablets 50mg; Procytox Vial 1000mg; Procytox Vial 200mg; Procytox for Injection 2000mg Pws IV

> <INTERNATIONAL_BRANDS>
Endoxan; Neosar; Procytox; Revimmune; Sendoxan

> <SALTS>
Cyclophosphamide monohydrate

$$$$